Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy3 maleimide non sulfonated 25mg'

Search results for: 'cy3 maleimide non sulfonated 25mg'

Items 21-30 of 66

Page
per page
  1. Vandetanib (ZD6474)
    A8555 Vandetanib (ZD6474)
    Target: VEGFR|EGFR
    Summary: VEGFR2/EGFR antagonist
      insoluble in H2O; ≥11.88 mg/mL
  2. FIIN-2
    A8696 FIIN-2
    Target: FGFR
    Summary: Irreversible inhibitor of FGFR
      ≥31.75 mg/mL
  3. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  4. PF-04217903 methanesulfonate
    A3712 PF-04217903 methanesulfonate
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      Soluble in DMSO
  5. GZD824
    B1402 GZD824
    Target: Bcr-Abl
    Summary: Bcr-Abl inhibitor,novel orally bioavailable
      ≥36.25 mg/mL
  6. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: orally bioavailable dual MER/FLT3 inhibitor
      ≥23.85 mg/mL
  7. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  8. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  9. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  10. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL

Items 21-30 of 66

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 4item
  2. Axl 2item
  3. ALK 5item
  4. c-Kit 1 item
  5. c-MET 7item
  6. CSF-1R 1 item
  7. EGFR 10item
  8. FAK 3item
  9. FGFR 5item
  10. FLT3 4item
  11. HER2 4item
  12. IGF1R 2item
  13. LRRK2 3item
  14. PDGFR 5item
  15. Pyk2 2item
  16. Spleen Tyrosine Kinase (Syk) 4item
  17. Src 3item
  18. Tie-2 2item
  19. Trk 2item
  20. VEGFR 15item
Specificity
  1. Selective 51item
Reversibility
  1. Reversible 6item
  2. Irreversible 6item
Target
  1. Raf 1 item
  2. CSF-1R 3item
  3. MER 1 item
  4. FLT3 6item
  5. VEGFR 18item
  6. PDGFR 12item
  7. c-Kit 4item
  8. RET 1 item
  9. Bcr-Abl 4item
  10. FGFR 10item
  11. MET 4item
  12. Src 6item
  13. Trk Receptors 3item
  14. STAT 1 item
  15. EGFR 10item
  16. FAK 3item
  17. BMP and Other Activin Receptors 1 item
  18. JAK 2item
  19. Syk 4item
  20. ErbB 2item
  21. c-MET 5item
  22. PKC 1 item
  23. Lyn 2item
  24. Pyk2 3item
  25. LRRK2 3item
  26. Insulin and Insulin-like Receptors 1 item
  27. ALK 3item
  28. ROS1 2item
  29. Angiotensin-Converting Enzymes (ACEs) 1 item
  30. Tie-2 2item
  31. 5-Lipoxygenases 1 item
  32. Insulin Receptors 1 item
  33. IRG-1R 1 item
  34. ZAP-70 1 item
  35. TAM kinase 1 item
  36. insulin 1 item
  37. PTK 1 item
  38. Flk1 1 item
  39. YES 1 item
  40. Fyn 1 item
  41. enoyl-acyl-carrier protein reductase 1 item
  42. tropomyosin receptor kinase 1 item
  43. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 1 item
  6. Breast Cancer 11item
  7. Cancer 47item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 2item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 5item
  13. Glioblastoma 1 item
  14. Glioma 3item
  15. Hepatocellular Carcinoma 3item
  16. Leukemia 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 3item
  19. Lymphoma 1 item
  20. Multiple Myeloma 3item
  21. Neuroblastoma 1 item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 4item
  24. Pancreatic Cancer 7item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 2item
  29. Thyroid Cancer 1 item